Type 1 Diabetes Management: Insulin Therapy, Monitoring, and Comprehensive Care

Type 1 diabetes (T1D) is absolute insulin deficiency from autoimmune β-cell destruction. Management requires lifelong exogenous insulin, glucose monitoring, and multidisciplinary care.

Insulin Regimens

Basal-Bolus (Physiologic):

  • Long-acting basal (glargine U100/U300, degludec, detemir) once/twice daily.
  • Rapid-acting bolus (lispro, aspart, glulisine, faster aspart) before meals + correction.
  • Carbohydrate counting, insulin-to-carb ratio, insulin sensitivity factor (ISF).

Insulin Pump (CSII): Continuous rapid-acting basal + bolus. Advanced: hybrid closed-loop (automated basal adjustment via CGM).

Premixed / Twice-Daily: Less flexible; for select patients unable to do basal-bolus.

Glucose Monitoring

  • CGM (Continuous Glucose Monitoring) – Standard of Care: Real-time (Dexcom G6/G7, Libre 2/3, Guardian) or intermittent (Libre). Metrics: Time in Range (TIR 70–180 mg/dL >70%), Time Below Range (<70 mg/dL <4%), GMI, variability.
  • SMBG (Fingerstick): Calibration, verification, backup.

Adjunctive Pillars

  • Nutrition: Carb counting, low-glycemic, individualized. No "diabetic diet."
  • Exercise: 150 min/week moderate + resistance. Adjust insulin/carbs for activity; prevent hypo/hyper.
  • Sick Day Rules: Never stop insulin. Check ketones (blood β-OHB) q3–4h if glucose >250 or ill. Extra rapid insulin per supplement scale. Hydrate. Seek care if ketones >1.5 mmol/L, vomiting, altered mental status.
  • Screening: Annual: dilated eye, foot exam, lipids, renal (UACR, eGFR), thyroid (T1D + autoimmune thyroiditis), celiac. Vaccines: flu, COVID, pneumococcal, Hep B.

Technology Integration

Automated insulin delivery (AID) systems (Tandem Control-IQ, Omnipod 5, Medtronic 780G, CamAPS FX) improve TIR, reduce hypoglycemia, decrease burden.

Diabetes - Related Articles